Please login to the form below

brigatinib

This page shows the latest brigatinib news and features for those working in and with pharma, biotech and healthcare.

Also picking up label extensions were Takeda’s Alunbrug (brigatinib), Boehringer Ingelheim’s Ofev (nintedanib) and Amgen’s Otezla (apremilast).

Pfizer’s Talzenna cleared for breast cancer in Europe

Alecensa (alectinib), Novartis’ Zykadia (ceritinib), and Takeda’s Alunbrig (brigatinib).
Pfizer gets EU nod for Tagrisso rival Vizimpro

Roche’s Alecensa (alectinib), Novartis’ Zykadia (ceritinib), and Takeda’s Alunbrig (brigatinib).
Pfizer files third-gen ALK inhibitor for lung cancer

Meanwhile another new entrant - Alunbrig (brigatinib) from Takeda - is also making headway after its first approval in 2017, making $13m by the end of the calendar year.
Roche gets FDA OKs for Alecensa and Zelboraf

A third rival, Takeda’s brigatinib, was approved for second-line use in May.
Novartis gets first-line approval for Xalkori challenger in EU

A third entrant into the market - Takeda's Alunbrig (brigatinib) - was given accelerated approval by the FDA as a second-line therapy a few weeks ago.

More from news
Approximately 2 fully matching, plus 13 partially matching documents found.

Deal Watch January 2017

With an enterprise value of $5.2bn this acquisition brings access to Iclusig (ponatinib), approved for chronic myeloid leukaemia (CML) and acute lymphoblastic leukaemia (ALL), as well as brigatinib in phase ... Takeda. Company acquisition. Oncology

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Jennifer Herron appointed as chief commercial officer of ARIAD

for Iclusig and, if approved, brigatinib.”. ... I look forward to working with the team to maximize the commercial performance of Iclusig, prepare for the potential US launch of brigatinib, and collaborate with R&D colleagues to further

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

No results were found

Add my company

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story: ...
New Playbook Alert: Virtual Patient Engagement: ...
Millennials: the wellness generation: Looking at the results from a global healthcare research study focusing on the patients of the future...

Email:
Password: